Biotechnology Companies By Bonds Weight

Bond Positions Weight
Bond Positions WeightEfficiencyMarket RiskExp Return
1ENGN enGene Holdings Common
97.03
 0.02 
 8.39 
 0.17 
2ALT Altimmune
15.26
 0.05 
 5.76 
 0.27 
3MBIO Mustang Bio
0.0
(0.03)
 5.74 
(0.17)
4MBRX Moleculin Biotech
0.0
(0.03)
 6.49 
(0.16)
5MCRB Seres Therapeutics
0.0
(0.04)
 6.49 
(0.23)
6037411AR6 APACHE P 6
0.0
 0.00 
 0.86 
 0.00 
7MDCX Medicus Pharma Ltd
0.0
 0.13 
 28.55 
 3.79 
8MDGL Madrigal Pharmaceuticals
0.0
 0.10 
 4.61 
 0.46 
9EQ Equillium
0.0
(0.02)
 7.84 
(0.14)
10KA Kineta Inc
0.0
(0.17)
 6.34 
(1.09)
11ME 23Andme Holding Co
0.0
(0.14)
 7.09 
(0.97)
12MDXG MiMedx Group
0.0
 0.17 
 4.31 
 0.72 
13MDXH MDxHealth SA ADR
0.0
(0.02)
 4.07 
(0.08)
14MEIP MEI Pharma
0.0
(0.08)
 2.34 
(0.19)
15MESO Mesoblast
0.0
 0.20 
 5.37 
 1.06 
16DMAC DiaMedica Therapeutics
0.0
 0.09 
 3.60 
 0.31 
17MGNX MacroGenics
0.0
 0.03 
 4.27 
 0.12 
18VALN Valneva SE ADR
0.0
(0.25)
 2.75 
(0.69)
19VANI Vivani Medical
0.0
 0.01 
 3.11 
 0.02 
20MGTX MeiraGTx Holdings PLC
0.0
 0.15 
 4.16 
 0.62 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Percentage of fund asset invested in fixed income securities. About 30% of U.S. mutual funds invest in bonds.Funds that have over 60% of asset value invested in bonds or or other fixed income securities would usually attract conservative investors.